Antimigraine drugs: new frontiers.
There are many acute care and preventive medications for the treatment of migraine. However, patients may often find that their headaches are not under optimal control. There are several targets that have been looked at and studied for the production of new, more effective medications. There are also effective devices for therapy of migraine. A list of targets will be put forth and a small number of them will be described in greater detail in this paper.
Department of Neurology, The David Geffen School of Medicine at UCLA in Los Angeles, 239 South Orange Drive, Los Angeles, CA 90036, USA. alanrapoport@gmail.com
A
A
Rapoport
D000279:Administration, Cutaneous; D000280:Administration, Inhalation; D000281:Administration, Intranasal; D000818:Animals; D001905:Botulinum Toxins / Q000008:administration & dosage / Q000627:therapeutic use; D000077221:Calcitonin Gene-Related Peptide Receptor Antagonists; D002491:Central Nervous System Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D017629:Gap Junctions / Q000187:drug effects; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy* / Q000517:prevention & control
D000077221:Calcitonin Gene-Related Peptide Receptor Antagonists; D002491:Central Nervous System Agents; D003692:Delayed-Action Preparations; D001905:Botulinum Toxins